Philip Weisshuhn

Associate

Dr. Phil, Dipl.-Biol.

Dr. Weisshuhn has been active in the field of intellectual property since 2019 and is authorized to represent clients before the German Patent and Trademark Office, the German Federal Patent Court, and the German Federal Supreme Court (in related appeals). His expertise complements df-mp’s strengths in the Pharmaceuticals, Biotechnology, and Chemistry Divisions.

+ 49 89 210 296 0
philip.weisshuhn@df-mp.com

Philip Weisshuhn

Associate

Dr. Phil, Dipl.-Biol.

Dr. Weisshuhn has been active in the field of intellectual property since 2019 and is authorized to represent clients before the German Patent and Trademark Office, the German Federal Patent Court, and the German Federal Supreme Court (in related appeals). His expertise complements df-mp’s strengths in the Pharmaceuticals, Biotechnology, and Chemistry Divisions.

+ 49 89 210 296 0
philip.weisshuhn@df-mp.com

practice areas.

Dr. Weisshuhn has extensive experience in the biotechnology industry and possesses a comprehensive scientific background, covering biochemistry, structural biology, cancer biology, and both clinical and preclinical research. His expertise encompasses patent prosecution, patent infringement, nullity actions, opposition and appeal proceedings, as well as conducting thorough Freedom-to-Operate (FTO) analyses.

admissions.

  • German Patent Attorney

references and activities.

  • Author and co-author of numerous scientific publications in the field of biochemistry

curriculum vitae.

Since 2023
Since 2023

Asso­cia­te at df-mp

2019-2023
2019-2023

Legal trai­nee at KUHNEN&WACKER, Frei­sing, Ger­man Patent and Trade­mark Office, Ger­man Fede­ral Patent Court, and at Land­ge­richt Mün­chen I

2017-2019
2017-2019

Busi­ness Deve­lo­p­ment Mana­ger in cli­ni­cal rese­arch, Cha­ri­té Rese­arch Orga­ni­sa­ti­on at Cha­ri­té – Uni­ver­si­täts­me­di­zin Ber­lin

2016-2017
2016-2017

Reci­pi­ent of EXIST Busi­ness Start-up Grant in bio­tech­no­lo­gy for crea­ting a GWAS and machi­­ne-lear­­ning approach to har­ve­st poly­ge­nic bio­mar­kers and drug tar­gets

2014-2016
2014-2016

Trader for Han Yale Ind. Co., Ltd., Tai­wan

2008-2013
2008-2013

Doc­to­ral stu­dent in the depart­ment of bio­che­mis­try, Uni­ver­si­ty of Oxford: struc­tu­ral stu­dies on the human Notch‑1 recep­tor with a Can­cer Rese­arch UK (CRUK) ful­ly fun­ded stu­dent­ship

2001-2007
2001-2007

Bio­lo­gy stu­dent at the Freie Uni­ver­si­tät Ber­lin in Ger­ma­ny and of bio­che­mis­try at the Uni­ver­si­dad de Valèn­cia in Spain, with a diplo­ma the­sis at the Max-Planck-Ins­ti­­tu­­te of Bio­che­mis­try in Munich; gra­dua­ted with distinc­tion

publications.

  • Weisshuhn, P.C., Handford, P.A., and Redfield, C. (2014). (1)H, (13)C and (15)N assignments of EGF domains 4 to 7 of human Notch-1. Biomol NMR Assign. 2015 Oct;9(2):275-9.
  • Weisshuhn, P.C., Handford, P.A., and Redfield, C. (1)H, (13)C and (15)N assignments of EGF domains 8 -11 of human Notch-1. Biomol NMR Assign. 2015 Oct;9(2):375-9.
  • Weisshuhn, P.C., Sheppard D., Taylor P., Whiteman P., Lea S.M., Handford P.A., Redfield, C. Non-Linear and Flexible Regions of the Human Notch1 Extracellular Domain Revealed by High-Resolution Structural Studies. Structure. 2016 Apr 5;24(4):555-66.
  • Dr. Philip Weisshuhn und Dr. Florian Kühbeck, Konservative Aminosäuresubstitutionen und Deep Learning bei der Definition von Antikörpern, Deutscher Anwaltsspiegel – Intellectual Property, Ausgabe 3, 24. August 2022